PRIMARY FOCUS
Since 2020, Remora Capital has re-focused its core investment strategy on:
-
Immunotherapy - using the patient own immune system to fight diseases
-
Oncology - the treatment of cancer
-
Best-in-class drug candidates - with a clear medical, industrial or economic added-value
-
New generation of biologics - more potent, cheaper or more convenient